Medicine guide
XBONZY
As listed in the register: XBONZY 120 mg, solution injectable
120 mg · solution injectable
- Prescription only
- Active substance
- Dénosumab
- Made by
- REDDY HOLDING (ALLEMAGNE)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | REDDY HOLDING (ALLEMAGNE) |
|---|---|
| Active substance | Dénosumab |
| Strength | 120 mg |
| Form | solution injectable |
| Route | sous-cutanée |
| Dispensing (as stated by the register) | prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE · prescription réservée aux spécialistes et services RHUMATOLOGIE · liste I · prescription réservée aux médecins compétents en CANCEROLOGIE |
| Marketed | Yes, according to the register |
| Reinforced monitoring | Yes — under reinforced monitoring, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/25/1982 |
| Name in the register | XBONZY 120 mg, solution injectable |
| Packs | 1 flacon en verre de 1,7 mL |
| CIS | 69177113 |
| CIP13 | 3400930331323 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.
ACVYBRA60 mgPrescription only REDDY HOLDING (ALLEMAGNE) · DénosumabBOMYNTRA120 mgPrescription only FRESENIUS KABI DEUTSCHLAND (ALLEMAGNE) · DénosumabCONEXXENCE60 mgPrescription only FRESENIUS KABI DEUTSCHLAND (ALLEMAGNE) · DénosumabDEGEVMA120 mgPrescription only TEVA (ALLEMAGNE) · DénosumabDENBRAYCE120 mgPrescription only MABXIENCE RESEARCH (ESPAGNE) · DénosumabENWYLMA120 mgPrescription only ZENTIVA (REPUBLIQUE TCHEQUE) · Dénosumab